A Systematic Review and Meta-Analysis of the Clinical Use of Megestrol Acetate for Cancer-Related Anorexia/Cachexia
Cancer-related anorexia/cachexia is known to be associated with worsened quality of life and survival; however, limited treatment options exist. Although megestrol acetate (MA) is often used off-label to stimulate appetite and improve anorexia/cachexia in patients with advanced cancers, the benefits...
Main Authors: | Yu Liang Lim, Seth En Teoh, Clyve Yu Leon Yaow, Daryl Jimian Lin, Yoshio Masuda, Ming Xuan Han, Wee Song Yeo, Qin Xiang Ng |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-06-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/11/13/3756 |
Similar Items
-
Megestrol acetate in cancer cachexia and anorexia: Tertiary care experience
by: Kaneez Fatima, et al.
Published: (2021-01-01) -
Megestrol acetate
by: 982 SIRIM -
Mirtazapine versus Megestrol in the Treatment of Anorexia–Cachexia Syndrome in Patients with Advanced Cancer: A Randomized, Double-Blind, Controlled Phase II Clinical Trial
by: Olga Laura Sena Almeida, et al.
Published: (2023-07-01) -
Efficacy of megestrol acetate in treatment of 21 young patients with endometrial adenocarcinoma
by: Eftekhar Z, et al.
Published: (2007-05-01) -
New Biopolymer Nanoparticles Improve the Solubility of Lipophilic Megestrol Acetate
by: Malwina Lachowicz, et al.
Published: (2016-02-01)